← Evidence map

SynthesisPharmacoEconomics2015

Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes.

Jinsong Geng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25736235